Amulet Capital Partners acquires SynteractHCR
Amulet Capital Partners (Amulet), a middle-market private equity investment firm focused exclusively on the healthcare sector, has acquired SynteractHCR Holdings Corporation (SynteractHCR), a contract research organisation (CRO) focused on Phase I‐IV clinical trials for emerging to mid-sized biopharma clients in the US, Europe and Asia. Terms of the transaction have